SCHEMBL10103535

SCHEMBL10103535

COCCC1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3537096 1.00
SCHEMBL20028834 0.88 SLC6A1 (0.38)
SCHEMBL1515463 0.88 SLC6A1 (0.38)
SCHEMBL255187 0.88 EED (0.42)
SCHEMBL792689 0.88 EED (0.42)
SCHEMBL24792369 0.88 SLC6A1 (0.38)
SCHEMBL2917543 0.86 CYP2D6 (0.31)
SCHEMBL791469 0.86 SLC6A4 (0.40)
Hydrochloric Acid SCHEMBL772083 0.86 EED (0.41)
Hydrochloric Acid SCHEMBL772084 0.86 EED (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112867715-B 5-azaindazole derivatives as adenosine receptor antagonists 默克专利股份公司 2024-03-05 CN disclosed
EP-3870582-B1 5-AZAINDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2023-07-19 EP disclosed
CN-105037382-B Bergenin analog derivative and its preparation method and application 中国药科大学 2017-08-25 CN disclosed
CN-105037382-A Bergenin derivatives, and preparation method and application thereof UNIV CHINA PHARMA 2015-11-11 CN disclosed
US-8518938-B2 c-MET protein kinase inhibitors VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-27 US disclosed
US-20120165333-A1 C-MET PROTEIN KINASE INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-06-28 US disclosed
US-7649001-B2 Fused benzene derivative and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-01-19 US disclosed
US-20090042857-A1 Novel Pharmaceutical TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-02-12 US disclosed